Private company

Stallergenes Greer

Swiss biopharmaceutical company

Stallergenes Greer International AG is a Swiss biopharmaceutical company specializing in the field of allergen immunotherapy. Headquartered in Baar, Switzerland, Stallergenes Greer International AG is the parent company of Greer Laboratories, Inc. (registered office in the U.S.) and Stallergenes S.A.S. (registered office in France).2 It employed 1,045 people.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2015Founded1
  • Industrypharmaceutical industry1
  • HeadquartersLondon1
  • Websitewww.stallergenesgreer.com
  • Legal formlimited company1
  • LEI213800CYVZA7GJQEME863
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered addressTOWER BRIDGE HOUSE, E1W 1DD London, United Kingdom3
  • Registered withCompanies House, 088060093

Stallergenes Greer International AG is a Swiss biopharmaceutical company specializing in the field of allergen immunotherapy.2

Corporate structure

Stallergenes Greer sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Stallergenes Greer London, United Kingdom
    • STALLERGENES Subsidiary · Antony, France

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

The story

Stallergenes was founded in 1962 by Institut Mérieux In 2015, Stallergenes and Greer Laboratories Inc. merged to form Stallergenes Greer.

Greer was founded by R.T. Greer, a collector of source materials (i.e.: roots, herbs, pollens) in 1904.

Stallergenes Greer is a privately held company owned by B-Flexion (ex Waypoint Capital), chaired by Ernesto Bertarelli.

From Wikipedia’s article on Stallergenes Greer, shared under CC BY-SA 4.0.4

Products and brands

Stallergenes Greer specialises in allergy immunotherapy treatments. It includes name patient products which are allergen products prepared in accordance with physician written prescriptions for individual patients.

The commercial product portfolio consists of sublingual products (Staloral, Oralair, Actair), subcutaneous products (Alustal/Albey), oral formulations (Palforzia), custom ordered bulk allergen extracts, veterinary products, and general laboratory consumables such as sterilized glass vials.

From Wikipedia’s article on Stallergenes Greer, shared under CC BY-SA 4.0.4

Timeline

  1. 2015Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4